Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.
about
Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamideNeuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats.Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.Novel antiepileptic drug lacosamide exerts neuroprotective effects by decreasing glial activation in the hippocampus of a gerbil model of ischemic stroke.Synergism of perampanel and zonisamide in the rat amygdala kindling model of temporal lobe epilepsy.Lacosamide modulates interictal spiking and high-frequency oscillations in a model of mesial temporal lobe epilepsy.Distribution of lacosamide in the rat brain assessed by in vitro slice technique.Increases of Catalase and Glutathione Peroxidase Expressions by Lacosamide Pretreatment Contributes to Neuroprotection Against Experimentally Induced Transient Cerebral Ischemia.
P2860
Q27014744-3DF5F88E-7FB7-4A00-A93E-82FEFBCBDB37Q33567241-7AF80111-3032-4E96-A239-FDC6CAC6A099Q33671879-C7E68637-4129-4886-9951-7C3E49C44A36Q36335408-4F70BD76-212E-4AE9-9547-4C28ED6FE5F6Q40016074-3B777CD6-DF48-4549-9FF2-50E7786DFE77Q42764730-B24949EF-AB43-4E76-839E-BBBA72BCD7D5Q47668140-6F39832E-0B4A-4A51-9529-3829963CBC40Q48719747-2279E33B-EA65-4DDC-B707-1D514825871E
P2860
Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Lacosamide treatment following ...... ical status epilepticus model.
@en
Lacosamide treatment following ...... ical status epilepticus model.
@nl
type
label
Lacosamide treatment following ...... ical status epilepticus model.
@en
Lacosamide treatment following ...... ical status epilepticus model.
@nl
prefLabel
Lacosamide treatment following ...... ical status epilepticus model.
@en
Lacosamide treatment following ...... ical status epilepticus model.
@nl
P2093
P2860
P356
P1433
P1476
Lacosamide treatment following ...... ical status epilepticus model.
@en
P2093
Alain Matagne
Christina Zellinger
Natalie Seeger
Thomas Licko
Vera Russmann
P2860
P304
P356
10.1111/EPI.12196
P577
2013-04-24T00:00:00Z